Cerivastatin
Alternative Names: BAY W 6228; Baycol; Certa; Cervasta; Cholstat; Lipobay; Liposterol; Micro®; Rivastatin; Selta; Staltor; Stativa™; Vaslip; Zenas MicroLatest Information Update: 05 Nov 2023
At a glance
- Originator Bayer
- Developer Bayer; Chiesi; Ferrer; Fournier Pharma; Fournier Pharma Inc; GSK; Laboratorios Vita
- Class Antihyperlipidaemics; Pyridines
- Mechanism of Action HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia; Low HDL cholesterol
Most Recent Events
- 24 Apr 2003 Groupe Fournier is now called Fournier Pharma
- 23 Aug 2001 Withdrawn for Hypercholesterolaemia in Japan (PO)
- 09 Aug 2001 Bayer has withdrawn cerivastatin worldwide except in Japan